Transitioning from Norplant to newer methods

Submitted by sestewar (not verified) on 7 October 2010 - 2:36pm

I see that under the Country Experiences tab there is a good piece on transitioning from Norplant to Jadelle in a Dominican Republic clinic. But many clients chose to remain with Norplant while it was still available.

Now that it has been phased out, how have programs and healthworkers managed the transition to newer products? Are there any counseling tips/advice beyond those outlined in the above article? Another article about introducing the new implants from a programmatic perspective outlines some issues such as costs, logistics, and service delievery. Has there been any in-country evidence that confirms or elaborates on these programmatic issues?

Implants Toolkit Discussion Board

Quick Links

Implanon

Jadelle

Sino-implant (II)

Long-Acting and Permanent Methods (LA/PMs)

Register for the e-conference on long-acting and permanent methods. Hosted by the SHOPS project, the conference will be held on May 8-10, 2012, and will discuss lessons learned about the private-sector provision of these methods.

Toolkit last updated: 18 April 2012

The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.